Allergan successfully concludes CFO search
February 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
UK Government to offer HPV vaccine to men who have sex with men
February 6, 2018Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination
The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …
PTx picks up radiation drug and plant from Sanofi
February 6, 2018Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical
A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …
BMS’ Opdivo and Yervoy combo better than chemo in halting lung cancer progression
February 6, 2018Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, NSCLC, Yervoy, lung cancer, opdivo, pharma
Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination …
Abbott teams up with Angle for metastatic breast cancer study
February 6, 2018Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma
Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …
Two former Greek PMs implicated in Novartis bribery case
February 6, 2018Manufacturing and Production, Medical Communications Greece, Novartis, biotech, drugs, pharma, pharmaceutical
An ongoing investigated case into Novartis sales practices in Greece has so far implicated 10 current and former politicians. The …
The future is now: The transformative power of AI
February 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma
With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
Rapidly-growing Nektar Therapeutics reportedly considering sale of its business
February 5, 2018Manufacturing and Production, Sales and Marketing M&A, MA, Nektar, Nektar Therapeutics, acquisition, pharma
After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …
UK GPs are “undervalued” with 40% looking to quit profession, study finds
February 5, 2018Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma
Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …
UK breast cancer mortality falls 10% over five years, overtaken by prostate deaths for first time
February 5, 2018Research and Development, Sales and Marketing Cancer, Cancer Research UK, breast cancer, pharma, prostate cancer
Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …
Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages
February 5, 2018Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …
64% of FDC antibiotics in India are unapproved, report reveals
February 5, 2018Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma
The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …
Top Ten most popular articles on Pharmafile.com this week
February 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten
It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …
Faslodex rejected by NICE for NHS breast cancer use
February 2, 2018Research and Development, Sales and Marketing AstraZeneca, Faslodex, NHS, NICE, UK, pharma
Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …
Array BioPharma demands $192m after AstraZeneca refuses to pay royalties
February 2, 2018Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib
Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for …
Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years
February 2, 2018Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia
Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …
Incidence of strokes in younger people rising
February 1, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, stroke
On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …
Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe
February 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life
Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …
NICE approves Perjeta for routine use on NHS
February 1, 2018Sales and Marketing Perjeta, Roche, biotech, drugs, pharma, pharmaceutical
NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …
FDA halts Bellicum trial over brain disease in participants, shares crash 48%
February 1, 2018Research and Development Bellicum Pharmaceuticals, FDA, encephalopathy, pharma, trial failure
Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
